Public Health Group Comments on US-Japan FTA

Asking for agreement with Japan to address the unique harms tobacco products cause and includes provisions to ensure that the U.S. and Japan don’t face the threat of investor litigation from the tobacco industry.

Coalition Letter FY20 Drug Budget

Draws concern about moving the DFC and HIDTA programs out of ONDCP into other federal agencies and cutting ONDCP’s budget by over 95%.

FY20 House Ag-FDA Letter from Public Health Groups

Urging for approval of the authorized level of user fees ($712M) for the FDA to oversee tobacco products. Also urging the Subcommittee to not include any restrictions on FDA’s authority under the TCA to oversee tobacco products. 

FY20 House CDC OSH Letter from Public Health Groups

Asking to increase funding for the CDC and OHS by $100 million, for a total of $310 million for FY2020.

FY20 Senate CDC-OSH Letter from Public Health Groups

Asking to increase funding for the CDC and OHS by $100 million, for a total of $310 million for FY2020.

FY20 Senate Ag-FDA Letter from Public Health Groups

Urging the Subcommittee to approve the $712 million in user fees that the TCA authorized FDA to collect and spend for tobacco-related activities for FY 2020.

HR 2339 Letter- Reversing the Youth Tobacco Epidemic Act

Letter of overwhelming support for the Reversing the Youth Tobacco Epidemic Act.

McConnell-Kaine Letter

Shows support for Tobacco-Free Youth Act, but emphasizes the importance that the bill remains strongly protective of the public health throughout the legislative process, as the tobacco industry is expected to try to weaken the legislation as it moves forward.

Letter from Public Health Groups Opposing S.294 and Any Efforts to Exem

Letter is opposing S.294 and states FDA should retain oversight authority over all tobacco products, including all cigars. Urges Senator to oppose S.294 and any similar appropriations policy riders.